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Abstract
Background: Information technology tools such as shared patient-centered, Web-based medication platforms hold promise to
support safe medication use by strengthening patient participation, enhancing patients’ knowledge, helping patients to improve
self-management of their medications, and improving communication on medications among patients and health care professionals
(HCPs). However, the uptake of such platforms remains a challenge also due to inadequate user involvement in the development
process. Employing a user-centered design (UCD) approach is therefore critical to ensure that user’ adoption is optimal.
Objective: The purpose of this study was to identify what patients with type 2 diabetes mellitus (T2DM) and their HCPs regard
necessary requirements in terms of functionalities and usability of a shared patient-centered, Web-based medication platform for
patients with T2DM.
Methods: This qualitative study included focus groups with purposeful samples of patients with T2DM (n=25), general
practitioners (n=13), and health care assistants (n=10) recruited from regional health care settings in southwestern Germany. In
total, 8 semistructured focus groups were conducted. Sessions were audio- and video-recorded, transcribed verbatim, and subjected
to a computer-aided qualitative content analysis.
Results: Appropriate security and access methods, supported data entry, printing, and sending information electronically, and
tracking medication history were perceived as the essential functionalities. Although patients wanted automatic interaction checks
and safety alerts, HCPs on the contrary were concerned that unspecific alerts confuse patients and lead to nonadherence. Furthermore,
HCPs were opposed to patients’ ability to withhold or restrict access to information in the platform. To optimize usability, there
was consensus among participants to display information in a structured, chronological format, to provide information in lay
language, to use visual aids and customize information content, and align the platform to users’ workflow.
Conclusions: By employing a UCD, this study provides insight into the desired functionalities and usability of patients and
HCPs regarding a shared patient-centered, Web-based medication platform, thus increasing the likelihood to achieve a functional
and useful system. Substantial and ongoing engagement by all intended user groups is necessary to reconcile differences in
requirements of patients and HCPs, especially regarding medication safety alerts and access control. Moreover, effective training
of patients and HCPs on medication self-management (support) and optimal use of the tool will be a prerequisite to unfold the
platform’s full potential.
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Introduction
Medication Self-Management in Type 2 Diabetes
The prevalence of type 2 diabetes mellitus (T2DM) is steadily
growing and represents a challenge for health care systems
worldwide [1]. The complex nature of T2DM management
requires ongoing efforts by the patient in collaboration with
health care professionals (HCPs) and informal support networks.
Compared with other chronic conditions, T2DM management
requires extensive self-management behaviors of patients, such
as adhering to often complex medication regimens, lifestyle
modifications (eg, diet, physical activity), recognizing and
responding to symptoms, and managing acute episodes [2].
Patient education and promoting patients’ self-management has
long been recognized as an important strategy in diabetes
management [3].
Medication self-management, defined as the various tasks
patients must undertake to effectively manage their therapeutic
regimen and sustain safe medication use over the long term [4],
is a critical skill for patients with T2DM. Considering this
definition, taking medications is a complex, multistep task and
requires patients filling the prescription, understanding the
medication regimen, organizing and correctly taking the
medication, monitoring the intake, and then sustaining
medication use over time [4]. Research has demonstrated that
patients with T2DM often have an inadequate understanding
on how to safely take their medications and concerns regarding
the appropriateness and safety of their regimen [5,6]. Inadequate
understanding can lead to improper use, adverse drug events
(ADEs), and suboptimal adherence [7-9]. In fact, suboptimal
medication adherence is common among patients with T2DM
[10] and is associated with poor health outcomes [11].
Health Information Technology
Health information technology (HIT) that is patient-centered
[12], such as Web-based personal health records, creates new
opportunities to facilitate patients’ diabetes and medication
self-management and enhances patient outcomes [13-15]. The
use of these technologies can provide patients access to personal
medication information and essential resources to facilitate
informed decision making, promote communication between
patients and HCPs, and enhance patient engagement and
self-management [14,16], particularly in patients with chronic
conditions such as T2DM [16,17]. However, despite the
potential benefits of HIT, introducing new technology to health
care has proven difficult [18] and adoption rates are often low
[19]. Factors identified in the literature that inhibit successful
HIT implementation include inadequate funding, lack of IT
infrastructure, poor leadership, unrealistic timeline, and
inadequate end-user engagement and input [18,20]. Hence,
research emphasized the need to directly involve intended users
in requirement specification, design, and testing to ensure that
HIT matches users’ cognitive abilities and needs, and support
self-managed care [19].
User Requirements Elicitation
Utilizing a user-centered design (UCD) [21] will enhance closer
user participation throughout the entire development process
and result in better tailoring to user requirements and needs
[22,23]. Likewise, the FITT framework (Fit between Individuals,
Task, and Technology) highlighted that successful adoption of
a technology depends on the fit between the attributes of the
individual user, the task, and the technology [24].
Today, a vast number of mobile apps exist to help manage
outpatient medication use for diverse medical conditions. A
systematic review [25] found that most apps provided
medication reminders and half enabled creating a medication
history, list, or log, whereas only few helped patients to organize
their regimen and check for drug interactions. Overall, the
quality, content, and functionality varied greatly. Common user
criticism revealed technical malfunctions, poor compatibility
with complex or varying regimes, and absence of desired
features. The review concluded that further research is necessary
to improve the design, content, and features from a patient
perspective [25]. To date, only a few studies [14,26,27] have
reported user requirements regarding the design and
development of patient-centered HIT to support T2DM patients
in self-managing their medications [28]. Requirements reported
in these studies included reliable information on medication
side effects and interactions, electronic messaging, selectively
disclosing information, refill reminder functionality, and a
user-friendly format [14,26,27]. Although these studies provide
valuable information on user requirements, they have not elicited
the views of both user groups: patients and HCPs. In Germany,
diabetes care is largely provided in primary care with general
practitioners (GPs) and health care assistants (HCAs) playing
a key role in coordinating care, pharmaceutical treatment, and
patient education. Thus, involving patients as well as GPs and
HCAs as collaborative partners will help to identify what
functionalities users require to accomplish the medication
management tasks. Moreover, previous research has highlighted
that HCPs endorsement of HIT is pivotal to increase patients’
participation and sustain use over time [29,30]. E-medication
is a primary objective in Germany’s eHealth strategy; however,
the development of a national e-medication infrastructure is
slow and cumbersome [31].
Therefore, this study employed a UCD to identify necessary
requirements in terms of functionalities and usability of a shared
patient-centered, Web-based medication platform from the
perspective of patients with T2DM and their HCPs (GPs and
HCAs). Patients should be able to access, share, manage, and
maintain personal medication-related information through this
platform, with the intention of enhancing patients’ knowledge
and strengthening patients’ active participation, thus helping
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them to better self-manage their medications and support safe
medication use.
Methods
Research Design
A qualitative study based on focus groups was employed to
explore the views of patients with T2DM and HCPs on their
requirements of a shared patient-centered, Web-based
medication platform [32,33]. Focus groups provide the
opportunity for a group of people to explore and clarify their
perspectives than would arise in individual interviews, facilitated
by social interaction. This qualitative method is thus particularly
useful for exploring not only what people think but also how
they think and why they think that way [32]. The study was
conducted as part of a larger German research project called
INFOPAT (Information Technologies for Patient-Centered
Health Care, 2012-2016) [34] studying the needs of chronically
ill patients and their HCPs to develop tailored information
technologies (ie, Web-based medication platform) and a
medication communication intervention to facilitate medication
self-management, improve medication safety, and
patient-provider communication. Recruitment and study
procedures have also been described in detail previously [35,36].
Study Participants and Recruitment
Between April and July 2013, participants were purposefully
recruited from the Rhine-Neckar region in southwestern
Germany. The purposive sampling strategy aimed to achieve
variation in patient characteristics, including education, duration
of diabetes, and medication regimen to elicit a broad range of
experiences and requirements. German or Turkish-speaking
adults (largest ethnic minority in Germany) with a T2DM
diagnosis who were self-administering prescribed diabetes
medications (oral hypoglycemic agents [OHA] only or insulin
only or OHA and insulin) were approached personally through
3 channels: local self-help groups, GP practices, and during
routine appointments at the Heidelberg University Hospital.
There were no restrictions on age, nor was computer or internet
experience a prerequisite to take part in the study.
GPs and HCAs with diabetes expertise, and experienced in
caring for T2DM patients, were recruited by a letter through a
list of cooperating academic teaching and research practices
from different geographic locations. The sampling approach
aimed to ensure diversity in terms of practice size, urban/rural
location, and computerization in practice. All participants gave
informed written consent before study enrollment. Ethical
approval was granted by the Ethics Committee of the Medical
Faculty of Heidelberg University (no S-673/2012). Participants
received a compensation of 50 €.
Focus Groups
From May until July 2013, 8 focus groups with a total of 48
individuals, including 25 patients with T2DM, 13 GPs, and 10
HCAs, were conducted. Focus groups were conducted with 6-8
participants per group. Of these 8 groups, 4 groups included
only T2DM patients, 3 groups included GPs and HCAs, and 1
group included only GPs. Each session was facilitated in German
by an experienced moderator and comoderator (authors GB,
CM, or DO) with the assistance of a trained note taker. The
meeting with the group of patients of Turkish descent was
simultaneously translated into Turkish (due to limited German
language proficiency) by a bilingual Turkish project partner
who acted as a comoderator. Participants completed a brief
sociodemographic questionnaire anonymously in conjunction
with the focus group. Semistructured, pilot-tested interview
guides alongside a moderator guide were used to guide the
discussion. Interview guides were matched on key themes and
covered participants’ requirements and needs regarding a shared
patient-centered, Web-based medication platform. Topics
covered in the focus groups, as they pertain to this paper,
included open-ended questions and probes to encourage a broad
discussion about participants’ experiences with their medication
management, attitudes, and opinions toward using a Web-based
shared medication platform and its technological and content
requirements (see Multimedia Appendix 1 for sample questions).
At the beginning of each focus group, the moderator briefly
presented the general idea of a medication platform by a
PowerPoint presentation. Postfocus group debriefings were
conducted, and central themes were documented in a research
diary. Each focus group lasted between 110 and 130 min, and
was audio- and videotaped. Recruitment of new participants
ceased when no new themes emerged in the group discussions
[37].
Characteristics of Participants
Most patients had complex medication regimens (≥5 different
types of medications taken regularly per day, not restricted to
diabetes medication) and had on average 3 other chronic
conditions. Of 25 patients, 16 (64%) reported having access to
a personal computer/laptop and about half stated to use the
internet for medication-related information. Almost all HCPs
had an internet connection in their practice, and 8 out of 13 GPs
(62%) reported to use electronic decision support systems.
Tables 1 and 2 present demographic characteristics,
computer/internet use, and recruitment of patients with T2DM
and HCPs.
Data Analysis
Audio- and video recordings were fully transcribed by trained
staff with anonymity of participants completely protected and
reviewed by the moderator (GB) for accuracy. The observers’
notes and debriefing notes were synthesized and integrated into
the data analysis process. Data were analyzed iteratively using
qualitative content analysis to structure material in codes (labels
of condensed meaning units), subcategories, and categories
(themes) [38-40].
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Table 1. Characteristics of patients with type 2 diabetes who participated in the focus groups.
Patient focus groups (N=25)Patient characteristics
7 (28)Gender (female), n (%)
64 (8.6); 49-77Age (years), mean (SD); range
13.9 (10.6); 0.8-38Diabetes duration (years), mean (SD); range
3.4 (1.6); 1-7Number of other chronic conditions, mean (SD); range
First language, n (%)
18 (72)German
7 (28)Turkish
Number of different medications taken regularly per daya , n (%)
2 (8)1-2 medications
6 (24)3-4 medications
5 (20)5-6 medications
12 (48)≥7 medications
Diabetes medication, n (%)
13 (52)Oral hypoglycemic agents only
3 (12)Insulin only
9 (36)Oral hypoglycemic agents and insulin
Education/school years, n (%)
12 (48)Secondary school (9 years)
5 (20)Secondary modern school (10 years)
8 (32)Grammar school (13 years)
16 (64)Computer/laptop at home, n (%)
14 (52)Internet use at home, n (%)
12 (48)Internet use for medication-related information, n (%)
Recruitment through, n (%)
15 (60)Self-help groups
6 (24)Heidelberg University Hospital
4 (16)General practitioner practices
aNot restricted to diabetes medication.
Development of thematic categories was guided by priori
objectives identified in the interview guide while also allowing
new themes to emerge from the data [40]. Moreover, 2
researchers (GB, CM) independently read transcripts and notes
thoroughly and then coded data to establish subcategories and
categories through consensus. At first, transcripts were
deductively analyzed by assigning initial categories
corresponding to the interview guide. Next, material pertaining
to each category was analyzed inductively to refine
subcategories. If the data revealed new information not fitting
the preliminary coding scheme, categories were developed
inductively. Throughout the iterative process of revisiting the
data and connecting them with new insights, an initial coding
scheme was established [40].
The researchers used Atlas.ti (Version 7.0.80, Scientific
Software Development GmbH, Berlin, Germany), a qualitative
software package, for organizing and coding the data.
Researchers met regularly throughout the study to discuss
categories and subcategories until consensus on the final set of
categories was reached. By taking into account the number of
focus groups reporting specific requirements, prioritization of
requirements was possible.
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Table 2. Characteristics of participating health care professionals. DMP: disease management program. N/A: not applicable. PC: personal computer.
Professional focus groupsHealth care professional characteristics
Health care assistants (N=10)General practitioners (N=13)
10 (100)6 (46.2)Gender, (female), n (%)
38.6 (11.8); 21-5254.1 (9.2); 35-64Age (years), mean (SD); range
Structure of practice, n (%)
4 (40)4 (30.8)Solo practice
6 (60)7 (53.8)Group practice
1 (7.7)Practice sharing
1 (7.7)Ambulatory health center
Location of practice, n (%)
5 (50)6 (46.2)City center
1 (10)5 (38.5)Suburbia
4 (40)2 (15.4)Rural area
15.5 (12.5); 0-3524.5 (9.8); 6-40Years of work experience, mean (SD); range
10 (100)13 (100)Participation in DMP diabetes type 2, n (%)
3 (30)6 (46.2)Solely electronic documentation, n (%)
N/A8 (61.5)Use of electronic decision support systems, n (%)
9 (90)12 (92.3)Internet connection in practice, n (%)
8 (80)9 (69.2)PC with practice software connected to internet, n (%)
Recruitment through, n (%)
8 (80)12 (92.3)Academic teaching practices
2 (20)1 (7.7)Research practices
Results
User Requirements Regarding Functionalities and
Usability of a Shared Patient-Centered, Web-Based
Medication Platform
Focus group participants discussed their requirements in terms
of functionalities and usability of a shared patient-centered,
Web-based medication platform. Categories and illustrative
quotes are presented in more detail in the following section.
Overall, GPs and HCAs had similar requirements regarding the
medication platform as the great majority of codes were
mentioned by both groups. Thus, data from GPs and HCAs were
pooled together. For publication, the coding scheme and
quotations were translated into English by the first author
(German-native and fluent speaker of English) and thereafter
cross-checked by an English- and German-native speaking
coauthor (CM). Unique identifiers are used to protect
participants’ anonymity (P, patient; GP, general practitioner;
HCA, health care assistant; FG, focus group). To facilitate
readability, categories, subcategories, and associated codes are
presented in Tables 3 and 4. Moreover, requirements were
prioritized (+-++++) based on the number “(1-4)” of patient
and HCP focus groups reporting a specific requirement.
Functionalities of the Medication Platform
Participants’ expectations regarding functionalities of the
medication platform were divided into 5 subcategories: (1)
security, access control, and supported data entry; (2) safety
alerts, reminders, and notifications; (3) tracking medication
history; (4) support features; and (5) electronic messaging and
information sharing (see Table 3 and Multimedia Appendix 2).
Although patients and HCPs had mostly similar expectations
regarding functionalities, they had controversial views on
automatic interaction checks and safety alerts for patients and
on patients’ ability to control access to the platform.
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Table 3. Required functionalities of the medication platform.
HCPbPatientaSubcategory and code
Security, access control, and supported data entry
++++++++Data security and privacy
++++Rapid access in case of emergency
+++cPatient can customize and restrict access to platform
+++cPhysicians and HCPs need full access
+++Restrict entering and changing information in platform
++++++Simple data upload, automatic spell, and plausibility check
++++Interoperability with management software systems
Safety alerts, reminders, and notifications
++++cAutomatic interaction checks and safety alerts, trigger alert messages and visual clues to highlight interactions,
risks and contraindications, what to do and specific instructions for safe use
++++cOnly high-severity drug-drug interactions, allergy alerts, contraindications, duplicate medications, and what to do
(HCP perspective: physician judgment is needed)
+++Highlight potentially hazardous medications and provide specific precautions
++++Signalize new entries and changes made (eg, pop-up, colored)
++E-reminder to undertake medication reconciliation, counseling, and review of therapy
+E-reminders to support medication intake or discontinue intake
Tracking medication history
+++++++Complete medication regimen
++++Date of prescription, medication change, and update
++Person who entered or changed information
+++++++Reason for changes or discontinuing medication
+++++++Occurrence of adverse drug events
++Medication dispensing information from pharmacy
++Patients can add specific information (eg, over-the-counter medications, symptoms)
Support features
++++Search function
+++Medication possession calculator
++Insulin dose calculator
++++++Medication plan and information can be printed, and send electronically
Electronic messaging and information sharing
+Exchange of experiences and information between patients
+Electronic messaging between HCPs
aRequirements of patients with type 2 diabetes, prioritized according to the number (1-4) of focus groups reporting requirement.
bRequirements of health care professionals (HCP; general practitioners and health care assistants), prioritized according to the number (1-4) of focus
groups reporting requirement.
cControversial views between patients and health care professionals.
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Table 4. Requirements regarding usability of the medication platform.
HCPbPatientaSubcategory and code
User interface
+++++++Structured information according to diagnosis or therapeutic indication, long-term and
on-demand medication
++++++++Structured information in a chronological order
++++++++Intuitive design and navigation, tailored to users’ workflow
++++++Ergonomic presentation, large font size, customizable adaptation of information density
User-centered provision of information
++++++Lay and multilingual language, for example, evidence-based information
++++Glossary to support comprehensibility of medical terms, wiki to answer important questions
+++++Use of visual aids, clues, and videos to facilitate understanding of information
++User guide, provision of training, and links to additional support
aRequirements of patients with type 2 diabetes, prioritized according to the number (1-4) of focus groups reporting requirement.
bRequirements of health care professionals (HCP), prioritized according to the number (1-4) of focus groups reporting requirement.
Security, Access Control, and Supported Data Entry
Data security and privacy issues were intensively discussed
across all focus groups, and appropriate security and access
methods (eg, secure authentication) were fundamental for
patients and HCPs to use the platform. Participants stressed the
platform would contain sensitive information on diagnoses and
medications, which was potentially valuable for third parties
(eg, insurance companies, pharmaceutical industry). Hence,
several patients and HCPs mentioned concerns to become
“gläsern” (transparent, P2-FG3) and monitored by the platform:
I would not use it if it would be cumbersome to use.
That would be the first requirement—the handling.
And I would not use it if it had negative effects for the
patients or if I would expect more control of my work,
when I feel that it is going to be a surveillance tool
for my work or when I witness that insurances, border
authorities or someone else is interested in these data.
[GP2-FG4]
Accordingly, participants stated they had to decide whether the
benefits of using the platform would outweigh the theoretical
risks. On the other hand, participants requested an emergency
access functionality in the platform to enable physicians’ rapid
access to a patients’ current medication list and important
patient-related information (eg, allergies, intolerances, risk
factors). To be acceptable to them, most patients emphasized
they need to be in control of their data and the authorization of
different HCPs and significant others to access and add
information to their personal account in the platform:
The access would have to be very restricted and
controlled by myself. [P2-FG1]
Although most participants supported the general idea of a
patient-controlled platform, most HCPs did not support patients’
ability to withhold information or restrict access to certain
information. HCPs stressed that physicians need to be fully
informed about a patient’s regimen to make informed decisions.
Furthermore, participants had extensive discussions about who
should be able to enter and change information in the platform.
Most HCPs thought it was important to restrict entering and
changing information in the platform. For instance, physicians
can enter their own prescription but should not be able to change
medications prescribed and entered by other HCPs.
Furthermore, HCPs suggested that patients can enter
over-the-counter medications (OTCs) and symptoms
experienced in the platform but should not be allowed to change
or delete a physician’s prescribed medication. Otherwise, HCPs
stressed “I can no longer trust my own case” [GP1-FG4] and
perceived this would affect their liability as well as the reliability
of information in the platform. Likewise, one HCA emphasized:
The patient should have the possibility to add
something [to the platform], but it should be clear
that it comes from the patient, yes, so one always
knows, he [the patient] has added something. But he
[the patient] should not be able to delete anything…
[HCA1-FG2]
Besides, HCPs mentioned concerns about the accuracy of
patient-entered data. Although some patients stated they wanted
to enter and update information themselves, patients with limited
computer experience or skills said they wanted their GP,
functioning as a coordinator, to enter or upload prescription
information. Others stated they would ask relatives or friends
to support them entering information and using the platform.
A fundamental requirement for patients and HCPs was that the
platform facilitated easy access, entry, and upload of medication
information while maintaining high security standards. For
instance, both groups perceived an automated entry of
medication information was important for ease of use and a
prerequisite for acceptance of the platform.
The HCP groups underlined that patients with T2DM often get
prescriptions from different providers, for instance, GP,
specialist, or hospital, and buy OTCs directly at the pharmacy.
Thus, the platform should interoperate with different
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management software systems and enable an automatic data
upload. Many HCPs stressed they would not enter medication
information twice, in their own system and in the medication
platform:
The upload from the practice management software
should be automatic, that it isn’t more work to open
the platform in the practice management software. I
think this is very important because when there is an
administrative effort, it becomes difficult, but if there
are interfaces to the practice management software,
then it’s certainly a good thing… [GP1-FG4]
Some patients suggested adding new medications to the platform
could be simplified by scanning the medication barcode with
their mobile device or a barcode scanner. To illustrate this
suggestion, 1 patient said:
We have also heard here that we are sometimes simply
overwhelmed with our medications… because they
either constantly change or something else. Thus, the
system should be designed in a way that it is relatively
simple for me to put in my medications. And I have
to keep it [medication] up to date. I mean if this is
too complicated or takes too much effort… it is not
up to date. Then it’s of no use… as I said, if I handle
the system self-responsible, it must be easy, a
medication package has a barcode. Quickly, with the
mobile phone the number is scanned. Quickly, the
medication is entered. If I have to enter everything
each time by hand… that’s just too much. [P5- FG4]
Others emphasized if they entered a medication manually, the
platform should feature an automatic spell and plausibility
checker and provide an automatic word completion for a quick
entry.
Safety Alerts, Reminders, and Notifications
Safety alerts, reminders, and automated notifications were
well-discussed in all focus groups with differences detected in
patients’ and HCPs’ expectations. Most patients perceived they
lacked information on potential side effects, long-term effects,
and drug interactions of their prescribed medication and voiced
concerns regarding the safety of their regimen. Thus, many
patients reported to seek risk-related information from a range
of sources including their GP, specialist, community pharmacist,
local self-help group, friends, as well as Web-based (internet)
resources.
Accordingly, patients suggested the platform should provide
comprehensive risk-related information and automatically check
and highlight interactions (eg, drug-drug, allergy, food) in their
regimen.
I have to take lots of different medications…there
[patient information leaflet] you can read about
incompatibilities with this and that substance, but I
don’t even know at all which substance is in which
medication…it would be important, if I have my
medications in such a system that it automatically
reconciles: “Do these fit together at all?” I mean, I
always have to trust my doctor that he knows this, but
sometimes I have the feeling: “How does he know all
of this?” Because there is so much stuff he has to
know. Sometimes I have a bad feeling, whether he
really knows that…I have an insecurity with the
medications…I often have the feeling it is a calculated
risk… [P5-FG4]
Thus, several patients wished real-time safety alerts to pop-up
automatically indicating the severity of interactions in their
regimen, for instance, by using distinctive color-coding (eg,
according to traffic light, red=serious). On the other hand, 2
patients were also averse to receiving information on potential
adverse effects, as this may negatively influence their attitude
toward a medication.
Likewise, HCPs expressed hesitation about offering an automatic
interaction check to patients and mentioned concerns about how
patients dealt with this critical information, as in their view, this
could increase patient fear, encouraging nonadherence, and
numerous discussions. HCPs also noted that interactions in the
regimen of chronically ill patients are common, often not
avoidable, and needed to be judged by them. Over half of the
GPs reported to use electronic decision support systems for
prescription writing. Although GPs generally valued drug
interaction and allergy alerts during prescribing, they stated to
override these frequently due to little clinical significance and
extensive numbers of warnings. Nonetheless, HCPs believed
that patients need to be informed about the most relevant adverse
and long-term effects to monitor their own treatment and know
how to reduce potential risks. Thus, HCPs suggested only
showing relevant adverse effects, contraindications, duplicate
medications, allergy alerts, and high severity drug-drug
interactions to patients. At the same time, HCPs, however, also
recognized difficulties regarding liability and legal implications
when only certain warnings would be displayed in the platform.
The following exchange exemplifies this:
There are warnings; you have to go deaf, this doesn’t
help…only the absolute relevant warnings should
pop-up… [GP1-FG1]
Response of another participant:
This is not possible, because it is actuarially all
relevant, that’s the problem. [GP3-FG1]
When with every ACE inhibitor and
potassium-sparing diuretic it pops-up every time…
we know that, and this doesn’t help. So, it should
really only be what is relevant… so that the absolute
no-go’s pop-up. [GP1-FG1]
Both groups pointed out that it was necessary to concisely
describe the actions to be taken by patients in lay language in
the alert to mitigate potential adverse effects and to promptly
contact their treating physician.
A few participants also requested that the platform notified users
about potentially hazardous medications (eg, anticoagulation)
or medications with unclear benefits. In addition, patients and
HCPs thought it was necessary to highlight new entries or
changes made in the platform automatically, for instance, by
using visual clues (eg, pop-up, color):
That you do not have to check constantly if something
has been changed, at what time something has been
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changed, but that this actually runs automatically…
[HCA3-FG2]
In general, HCPs saw great value of the platform for medication
reconciliation and counseling by combining all relevant
medication information of a patient in one place. Hence, HCPs
were interested in setting up an automated prompt that reminded
them periodically to undertake medication reconciliation and
counseling. Similarly, some patients wished the platform enabled
setting up tailored audible medication-taking prompts that
reminded them to take their medications at specific time intervals
or, for instance, to discontinue intake before surgery. To enable
this feature, patients suggested the platform should be linked
to their mobile device.
Tracking Medication History
Tracking a patient’s medication history received great attention
in the group discussions and was perceived by all participants,
especially HCPs, as an essential component of the platform.
Participants were enthusiastic about the platforms’ potential to
increase the ease of documentation and produce a structured
presentation of a patient’s complete medication history (eg,
including prescription and nonprescription medication,
supplements), thus facilitating information exchange and
medication reconciliation across health care sectors and
professionals. HCPs underscored current challenges (eg,
resource and time constraints, lack of cross-sectorial
collaboration, and technical interoperability, drug discount
contracts) in reconciling medications of their chronically ill
patients, particularly during transitions of care. For the patient
groups, capturing their medication history was relevant to see
how their condition and treatment developed over time. Several
patients described how they kept track of their currently and
previously used medications by creating paper-based medication
lists where they documented changes (eg, regarding dosage,
frequency, and generic substitution) made in their regimen and
related these to clinical parameters (eg, glycated hemoglobin):
What is important for me, I always make a note when
I changed the dosage or the medication […] that I
can enter it [in the platform] and that I know the
dosage has been […] that’s a thing I like to check.
Has it improved or worsened since the change. I found
this was very important and have written it down next
to it. [P3-FG1]
Moreover, patients stressed that medication changes are
common, often tied to specific problems or therapeutic goals,
and without documentation, they would have difficulties keeping
track of this information. HCPs underlined often not being fully
informed about a patient’s medication regimen as only the
patients are in the position to account for their self-medication.
Thus, patients should enter OTCs and symptoms experienced
to complete medication history taking. HCPs, however,
experienced that patients had difficulties disclosing their
co-usage of OTCs, vitamins, or herbal supplements. Hence,
HCPs suggested patients would need prior guidance on the
importance of accurately documenting prescription and
nonprescription medications in the platform. Above all,
participants across focus groups emphasized it was crucial to
consistently record reasons for changing or discontinuing
medications in a patient’s medication history, including
information on side effects, ADEs, and intolerances. This
information was perceived vitally important to make informed
treatment decisions and ensure patient safety. In addition,
participants stressed the platform should automatically capture
the name of the person (eg, patient, prescribing physician,
dispensing pharmacy) entering data as well as the date of each
transaction:
I would like to have a medication history, who
prescribed and discontinued what, when and
why…because often with chronically ill patients there
are let’s say circular procedures: Medication A,
Medication B, Medication C, Medication A and then
the question arises: did he not tolerate it? After some
time, the patient doesn’t know it anymore and I have
to admit sometimes I’m not either…to have a comment
field to record the reason for discontinuing the
medication, due to intolerance, allergy, medication
change, hospital stay, ineffectiveness or so on.
[GP2-FG4]
Documentation of possible adverse drug reactions
with date of occurrence. That there is somewhere a
note, there have been adverse effects. After five years
I forgot that one [a patient] on Amlodipin got edemas
and I will prescribe it again, then it happens again.
There are also more severe adverse effects…
[GP2-FG2]
If a medication is changed that the date is recorded
when it was changed and what was prescribed
instead… [HCA2-FG2]
Furthermore, in participants’ view, medication dispensing
information from the pharmacy (eg, date of dispensing, generic
substitution, and initials of dispensing pharmacy) would shed
light on generic substitution and may improve patients’
comprehension. Thus, the platform should clearly link the
patients’ prescribed medication with the dispensed generic
medication.
Support Features
Participants suggested incorporating support features to facilitate
retrieval of information in the platform and to help organize
daily medication taking. Due to large amounts of data stored in
the platform, participants stressed the platform should contain
a search function allowing rapid retrieval of information. To
support patients’ self-management, many participants wished
to be able to print relevant information (eg, medication list,
specific directions for use, and administration) as well as to
send information electronically. Participants also highlighted
they would benefit if the platform offered a feature to calculate
medication possession (ie, number of refills remaining) and the
amount of insulin units needed to reach a target blood glucose
concentration, as the following discussion illustrates:
It would be practical…if the platform would list, when
one has to get a refill, so one can plan ahead…
[HCA1-FG3]
I have another idea. I have insulin-dependent diabetes
and fly to New York…or further [across several time
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zones] How do I have to adjust my insulin dosage
now? There are great calculations models available…
[GP3-FG3]
So, I would even say that one could also specify the
time period, so that one knows how much he has to
take with him… [HCA1-FG3]
Electronic Messaging and Information Sharing
The potential of the platform to enable electronic messaging
among users was only discussed briefly and revealed
controversial aspects among focus group participants. A small
number of patients said they would like to share information
and personal experiences, for example, with certain medications,
adverse effects, or alternative treatment options, with their peers
through an integrated anonymous chat or online user forum:
I have recognized it right from the beginning how
each of us told about his illnesses and so on. I heard
about this and that. Aha! That’s the same with me.
There [relating to the platform] it is possible to
exchange certain experiences. Surely, I cannot say,
[…] you have to do this and that. That doesn’t work.
But you can get suggestions and maybe you see:
others are in the same situation. He has psychological
problems with all of that—same with me. I know I am
not alone. There are others who have the same
problems. This experience by itself is very helpful…
[P5-FG4]
Although patients generally saw value in exchanging
experiences with their peers, they also voiced concerns regarding
reliability and credibility of information exchanged. A few HCPs
responded positively to communicate with other HCPs regarding
a patient’s medication regime (ie, to resolve discrepancies)
through the platform, particularly during transitions of care.
However, the majority of HCPs were reluctant to communicate
electronically with other providers and, especially not with
patients, and feared an increased workload. Furthermore, they
emphasized it should not be used for urgent matters as it would
be impossible to answer requests in a timely manner:
...I imagine regular consultation hours. I don’t read
emails or do chats. I have no time for that during
consultation hours; I must say clearly. In our practice,
we have even stopped interruptions by telephone
except in real emergencies... [GP4-FG3]
Usability of the Medication Platform
Participants’ expectations regarding usability of the medication
platform were grouped into 2 subcategories: (1) user interface
and (2) user-centered provision of information (see Table 4 and
Multimedia Appendix 3). Overall, patients and HCPs expressed
similar expectations on the issue of usability.
User Interface
Patient and HCP groups emphasized that medication information
should be displayed in a clear and logical manner in a large font
size on the platform. For instance, participants suggested listing
medications in a chronological order, organizing them according
to diagnosis (eg, T2DM, cardiovascular), and categorizing
medications in relation to their short-term (eg, an antibiotic) or
long-term use (eg, OHA):
The medication platform should be simply structured,
there should be the long-term medications, then the
on-demand medications or short-term medications,
and easily accessible and changeable… [GP3-FG1]
Overall, to support a patient’s self-management, participants
highlighted that the platform should be easy to navigate, to
enable quick access to relevant medication information, and to
observe a patient’s current medication at a glance. After log in,
the current medication list should be prominently displayed on
the front page, thus enabling a quick overview of a patient’s
current medication. Likewise, participants commented it was
important that the platform provided sufficient information to
make informed decisions but at the same time was not
overloaded with information:
However, one should not overload such a system,
because otherwise you don’t find anything and have
to search… [GP4-FG3]
Consequently, participants requested the platform should enable
users to customize information density. For instance, some
participants suggested to provide access to detailed information
(eg, regarding side effects) via a link on the specific medication.
Especially HCPs groups expected the platform to be tailored to
suit their practice workflow and to function quickly and reliably.
User-Centered Provision of Information
From the participants’ point of view, a user-centered provision
of information in the platform was fundamental for the adoption
and successful use by patients and HCPs. Most patients
described their difficulties understanding medication information
in consultations and in written information leaflets. Accordingly,
patients as well as HCPs stressed that information should be
evidence-based and provided in “nontechnical jargon” [P6-FG4]
in the platform. In addition, the group of Turkish patients
remarked it was important that the platform provided access to
multilingual information. Both groups thought it would be
beneficial to provide a glossary or encyclopedia to support
comprehensibility of medical terms and a wiki for answering
important and frequently asked questions:
Yes, common misunderstandings, frequently asked
questions and common medication intake errors…
[HCA4-FG2]
Especially the patient focus groups highlighted they would
benefit if visual aids (eg, icons, pictograms, images of
medications, daily injection plan) and videos (eg, instruction
video) were included in the platform to assist identifying,
understanding, and using their medications appropriately:
When it comes to injection technique, a video would
be very helpful… [P2-FG1]
HCPs also emphasized to integrate visualization methods into
the platform:
It would be great if you click on a medication a video
is shown or something else… [GP2-FG2]
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Besides, patients’ desired prior instruction and training for using
the new system and some requested a toll free hotline and a user
guide to aid navigation. Furthermore, patients wished the
platform linked them to an expert helpline for personal
medication counseling and further self-management support
(eg, regional patient support groups).
Discussion
Principal Findings
The qualitative UCD approach enabled a deeper understanding
of the requirements of patients with T2DM, GPs, and HCAs
regarding functionalities and usability of a shared
patient-centered, Web-based medication platform. Identifying
key users’ requirements early on is a critical step in the
development and implementation of a new system to
successfully support medication management and treatment of
patients with T2DM and their HCPs.
In patients’ view, a medication platform offers potential to
improve their understanding, address their medication-related
concerns, and support their medication self-management
activities. HCPs, in turn, focused on the platforms’ ability to
aid comprehensive medication history taking and reconciliation
across health care settings. Appropriate security and access
methods, supported data entry, printing and sending information
electronically, and tracking medication history were perceived
by participants as essential functionalities. Although patients
wanted automatic interaction checks and safety alerts, HCPs,
on the contrary, were concerned that unspecific alerts confuse
patients and lead to nonadherence. Furthermore, HCPs were
opposed to patients’ ability to withhold or restrict access to
information in the platform. To optimize usability, there was
consensus among participants to display information in a
structured, chronological format, to provide information in lay
language, to use visual aids and customize information content,
and align the platform to users’ workflow.
Most participating patients had safety concerns, and prior
research suggested that patients most commonly avoid taking
their medications due to concerns about adverse effects [5]. To
address these concerns, patients desired comprehensive
risk-related information, automatic interaction checks, and safety
alerts in the platform. Undeniably, patients play a central role
in managing medication-related risks, and need to be engaged
in self-monitoring to improve medication use [41]. Keeping in
mind that patients with T2DM often have complex medication
regimens and receive pharmaceutical treatment from different
providers, tailored and clinically meaningful safety alerts
combined with clear instructions on how to proceed could
facilitate early detection and reduce serious complications. On
the other hand, some patients may not want or feel capable to
use safety-related IT apps. Thus, it will be necessary to
customize safety alerts to the specific needs of individual
patients, for instance, to allow triggering the interaction check
manually (ie, non-interruptive) or showing only high severity
alerts. To date, however, lack of specificity and low sensitivity
of medication alerts in clinical decision support systems is still
a problem [42,43]. Comparable with HCPs’ concerns,
unmodified medication safety alerts without concurrent
physician interpretation may create confusion and anxiety among
patients and thus impede medication-taking. At this point, it is
important to emphasize that the medication platform does not
replace or substitute for patient-provider consultation but has
the potential to complement instructions and self-management
support given. Furthermore, the platform offers potential to
transmit essential information (eg, access to complete medication
regimen, diagnoses) among members of the health care team.
This may, for instance, promote stronger physician-pharmacist
collaboration to improve medication therapy and safety. Overall,
however, HCPs had conflicting views regarding the provision
of risk-related information in the platform. Most HCPs held
negative attitudes toward safety alerts for patients and also
anticipated an increase in their workload. Nevertheless, they
perceived patients should be made aware of the most relevant
adverse effects. Delbanco and colleagues [44] found that patients
who had electronic access to care providers’ notes felt more in
control of their care, and reported improved medication
adherence and minimal concerns without increasing providers’
workload. Hence, unintended consequences to patients need to
be explored further in the user-driven design process to see if
the platform and specifically safety alerts are both beneficial
and acceptable to patients and HCPs and exceed potential risks
[43]. Perhaps patients may have a more sensible approach to
safety alerts than HCPs fear.
Patients’ ability to control and restrict access to
medication-related information or change physicians prescribed
medication evoked great concerns (ie, medicolegal liability)
among HCPs and was perceived to threaten physicians control
and the quality of care. Thus, patients’ desired ownership over
the platform seems to clash with the predominant approach held
by HCPs. Similar to previous research [45], physicians were
concerned to make suboptimal decisions about a patient’s
treatment due to incomplete or inaccurate information. In
contrast, Haverhals et al [26] also concluded that health apps
should provide patients the ability to selectively disclose
information (eg, alternative medications) to different HCPs.
Further research and ongoing involvement of intended users is
therefore necessary to elaborate how to place control of the
medication platform in the hands of patients while accounting
for HCPs’ needs. Moreover, introducing such a patient-held
information system challenges current structures and requires
a shift in patients’ and HCPs’ roles and responsibilities.
One of the greatest concerns among patients and HCPs were
privacy and security issues, which seems more prominent in
Germany than in many other countries, and thus delay a national
e-medication initiative [31]. Security and privacy concerns,
however, have also been identified previously as a potentially
large barrier to personal health record use [16,46]. Further
investigation of privacy, security, and legal concerns is needed
to better understand what prompts these concerns by patients
and HCPs and to ensure that users’ concerns are adequately
addressed. Moreover, ways of granting secure and effective
emergency access to the medication platform need to be
explored in the iterative development process.
Participants were enthusiastic about the platforms’ potential to
collect and store a patient’s complete medication history in a
structured format by engaging both patients and HCPs. Indeed,
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medication errors are common in primary care and there is a
need for better monitoring, patient education, and improved
communication between patients and their HCPs [8,47].
Although participants positively viewed patients’ ability to
contribute their self-medication and symptoms (eg, ADEs,
intolerances) to the platform, some HCPs also mentioned
concerns regarding reliability and accurateness of patient-entered
data. Tang and colleagues [16] emphasized that the reliability
of data entered by patients depends on the nature of information
per se, the patient’s literacy level, and the motivations for
recording the data. Providing data entry functionalities in the
platform, for example, scanning the medication barcodes with
a mobile device and integrating a plausibility checker, may help
to improve information accuracy. Moreover, effective training
of patients and HCPs will be a prerequisite to unfold the
platform’s full potential. Overall, facilitating patient engagement
in medication history collection seems a promising approach
to improve medication reconciliation, patient-provider
communication, and thus patient safety [48].
Although the platform may offer new ways to mediate
communication among patients and HCPs, this function received
only little attention in the focus group discussions and was
subject to concerns. Although patient medication reviews have
also been identified previously as a valuable complementary
source of information for patients [49], the reliability of this
information has likewise been questioned [50]. Nevertheless,
patient online communities have been suggested to facilitate
patients’ comprehension, informed decision making, and
medication self-management [51]. Despite evidence that patients
increasingly desire Web-based patient-provider communication
[52], patients in this study did not request Web-based messaging
with their HCPs. Maybe patients did not expect it to be an
effective way to communicate with their HCPs about their
medications or generally lacked ideas how the platform could
facilitate patient-provider communication. Likewise, HCPs were
reluctant to communicate electronically with patients, although
a few HCPs saw potential for medication reconciliation through
secure messaging with other HCPs.
Patients and HCPs had similar expectations regarding usability
of the medication platform. For both groups, it was essential
that the platform structured information chronologically in an
intuitive, user-centered format (eg, customizable content in lay
and multilingual language) on 1 screen and aligns to users’
workflow. As also proposed earlier [16,30], special attention
needs to be paid to health literacy issues when developing such
a platform. Visual aids, pictograms, and customized videos
requested by participants can enhance patients’ understanding
of how they should take their medications [53,54]. However,
there are additional skills in terms of accessing and effectively
using HIT, subsumed as eHealth literacy, that are required to
fully engage with eHealth resources [55]. To date, patients and
HCPs have not been trained sufficiently in the optimal use and
implementation of HIT in medication management [56]. It is
therefore vital that all essential aspects of using and
implementing the medication platform should be included in
the training, telephone, and on-site support [57]. Moreover,
prior education of patients and HCPs on medication
self-management (support) is vital to equip users with the
essential skills and thus have implications for realizing the
potential benefits of the platform. Further developments of the
platform should also explore and incorporate features (eg,
electronic diary, self-monitoring tools, nutrition module) that
help patients to adopt and maintain a healthy lifestyle [2].
Strengths and Limitations
A strength of this qualitative study is that the in-depth
perspectives of patients with T2DM who were diverse in age,
duration of diabetes, and on a variety of medication regimes
and their primary HCPs, including GPs and HCAs, were
collected. By applying the principles of UCD, intended users
have been involved early in the design and development process
of the medication platform and thus increase the likelihood to
achieve a functional and useful system. Although participants
were purposefully selected and recruited from different health
care settings, they may not be generalizable to the diabetes
patient population or HCPs overall. As participants “opted in”
to the focus groups, they may have greater interest in medication
management and HIT, and may represent the perspectives of
“early adopters,” although computer experience differed among
participants. Although this provides valuable insights on the
needs of early adopters of HIT, we do not know the perspectives
of potential participants who chose not to participate. Moreover,
this study did not specifically focus on low-literate patients,
their caregivers, or other HCP groups. Incorporating their
perspectives may have generated a more extensive requirements
elicitation. Despite the limitations, this study enables a
comprehensive description of patients’ and primary HCPs’
requirements regarding a shared patient-centered, Web-based
medication platform and will ultimately help to design the
platform according to these needs.
Conclusions
The need to explore new approaches to facilitate medication
management and treatment across health care sectors is an
important issue that becomes increasingly important with the
number of patients with T2DM. Given that patients are in control
of their daily diabetes care [58] and the central users of the
prospective system, their requirements need to be taken into
account. This must, however, always be regarded in relation to
the respective health literacy of each patient. No
“one-size-fits-all” solution seems to be possible. The platform
will be needed to be tailored to patients’ needs and capabilities.
Furthermore, reconciling differences in requirements of patients
and HCPs, especially regarding medication safety alerts and
access control, will necessitate substantial engagement by all
intended user groups in the ongoing development process.
Balancing patients and HCP’s preferences is a prerequisite to
empower patients and improve medication management and
safety, while encouraging HCPs to use the platform. Once the
prototype is developed, its evaluation will show how patients
and HCPs evaluate and use the system, showing if the system
has a good FITT and promotes the intended health outcomes.
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